Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 5/30
$0.99+0.07 (+8.07%)
Close on Nov 18, 2026Market cap $51.51MP/E –Yield –
Rafael operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Rafael's operating cash flow for the twelve months ending Jul 31, 2026 was -$29.99M. For fiscal 2026 it was -$29.99M. The highest annual figure on record is $72.00K in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -$29.99M | – |
| FY2025 | Jul 31, 2025 | -$18.92M | – |
| FY2024 | Jul 31, 2024 | -$7.80M | – |
| FY2023 | Jul 31, 2023 | -$10.89M | – |
| FY2022 | Jul 31, 2022 | -$26.08M | – |
| FY2021 | Jul 31, 2021 | -$15.60M | – |
| FY2020 | Jul 31, 2020 | -$4.67M | – |
| FY2019 | Jul 31, 2019 | -$3.13M | – |
| FY2018 | Jul 31, 2018 | -$1.82M | – |
| FY2017 | Jul 31, 2017 | -$1.62M | -2354.2% |
| FY2016 | Jul 31, 2016 | $72.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -$8.37M | – |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -$7.28M | – |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | -$7.52M | – |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | -$6.81M | – |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -$10.38M | – |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -$3.19M | – |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -$2.32M | – |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -$3.04M | – |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | -$2.89M | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -$251.00K | – |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | -$2.53M | – |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -$2.13M | – |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | -$1.45M | – |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -$1.31M | – |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -$5.54M | – |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -$2.58M | – |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -$1.90M | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$10.37M | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$7.34M | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$6.47M | – |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -$6.98M | – |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -$3.09M | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -$2.87M | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -$2.65M | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -$1.69M | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -$1.08M | – |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -$964.00K | – |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -$936.00K | – |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -$594.00K | – |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -$1.64M | – |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -$175.00K | -350.0% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -$724.00K | – |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -$745.00K | – |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -$1.11M | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $70.00K | – |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -$29.00K | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -$1.15M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -$110.00K | – |
See a number that looks wrong?